Impact of adjunct bezlotoxumab for preventing Clostridioides difficile infection recurrence in patients post - hematopoietic stem cell transplantation.
Saved in:
| Title: | Impact of adjunct bezlotoxumab for preventing Clostridioides difficile infection recurrence in patients post - hematopoietic stem cell transplantation. |
|---|---|
| Authors: | Patel M; Department of Pharmacy, SSM Health Saint Louis University Hospital, Saint Louis, MO, USA., Gill CM; Department of Pharmacy, SSM Health Saint Louis University Hospital, Saint Louis, MO, USA., Chamberland R; Department of Pathology, Saint Louis University, Saint Louis, MO, USA., Heflin T; SSM Health Saint Louis University Hospital, Center for Blood and Marrow Transplant, Saint Louis, MO, USA., Mehringer R; Department of Pharmacy, SSM Health Saint Louis University Hospital, Saint Louis, MO, USA. |
| Source: | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2026 Jun; Vol. 32 (4), pp. 676-681. Date of Electronic Publication: 2025 Jan 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
